X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (60) 60
humans (54) 54
female (46) 46
animals (41) 41
oncology (27) 27
mice (24) 24
ovarian cancer (20) 20
aged (19) 19
cell line, tumor (19) 19
male (19) 19
middle aged (19) 19
cancer (17) 17
analysis (15) 15
expression (15) 15
ovarian neoplasms - pathology (15) 15
adult (12) 12
chemotherapy (12) 12
mice, nude (11) 11
multidisciplinary sciences (11) 11
aged, 80 and over (10) 10
cell biology (10) 10
health aspects (10) 10
hidden markov models (10) 10
ovarian neoplasms - metabolism (10) 10
phosphorylation (10) 10
research (10) 10
xenograft model antitumor assays (10) 10
article (9) 9
dose-response relationship, drug (9) 9
mice, inbred balb c (9) 9
molecular sequence data (9) 9
ovarian neoplasms - drug therapy (9) 9
therapy (9) 9
cells (8) 8
medical research (8) 8
proteins (8) 8
rats (8) 8
amino acid sequence (7) 7
angiogenesis (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
apoptosis (7) 7
mathematical models (7) 7
medicine (7) 7
medicine & public health (7) 7
ovarian neoplasms - genetics (7) 7
prognosis (7) 7
research article (7) 7
retrospective studies (7) 7
studies (7) 7
tumors (7) 7
antineoplastic agents - pharmacology (6) 6
biochemistry & molecular biology (6) 6
cancer therapies (6) 6
cervical cancer (6) 6
data models (6) 6
gene expression (6) 6
gene-expression (6) 6
genetic aspects (6) 6
medicine, experimental (6) 6
metastasis (6) 6
neoplasm staging (6) 6
patients (6) 6
pharmacology & pharmacy (6) 6
plant sciences (6) 6
pregnancy (6) 6
rho (6) 6
signal transduction (6) 6
survival (6) 6
time series analysis (6) 6
biomarker (5) 5
carcinoma (5) 5
cell movement - drug effects (5) 5
cell proliferation (5) 5
cell proliferation - drug effects (5) 5
cyclophosphamide (5) 5
diagnosis (5) 5
drug therapy (5) 5
endocrine system diseases (5) 5
endocrinology & metabolism (5) 5
growth (5) 5
human (5) 5
immunology (5) 5
in-vitro (5) 5
microrna (5) 5
migration (5) 5
neoplasm invasiveness (5) 5
ovarian carcinoma (5) 5
peritoneum (5) 5
phase-ii (5) 5
time factors (5) 5
time series (5) 5
time series signal processing (5) 5
accessories (4) 4
activation (4) 4
administration, oral (4) 4
angiogenesis inhibitors - pharmacology (4) 4
antibodies (4) 4
arabidopsis - cytology (4) 4
arabidopsis - metabolism (4) 4
arabidopsis proteins - metabolism (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular Cancer Research, ISSN 1541-7786, 01/2017, Volume 15, Issue 1, pp. 78 - 92
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2015, Volume 5, Issue 1, p. 18217
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2017, Volume 114, Issue 35, pp. E7301 - E7310
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2015, Volume 10, Issue 2, p. e0118080
Ovarian cancer remains the most lethal gynecologic cancer and new targeted molecular therapies against this miserable disease continue to be challenging. In... 
M2 MACROPHAGES | METASTASIS | ASCITES | TUMOR PROGRESSION | PATHWAY | MULTIDISCIPLINARY SCIENCES | IN-VIVO | ANTIBODY | EXPRESSION | CELL CARCINOMA | TOCILIZUMAB | Vascular Endothelial Growth Factor A - biosynthesis | Prognosis | Humans | Middle Aged | Molecular Targeted Therapy | Lipopolysaccharide Receptors - metabolism | Young Adult | Neoplasm Grading | Aged, 80 and over | Adult | Female | Ovarian Neoplasms - metabolism | Interleukin-6 - metabolism | Ovarian Neoplasms - drug therapy | Gene Expression | Macrophages - pathology | Paracrine Communication | Ovarian Neoplasms - diagnosis | Receptors, Interleukin-6 - genetics | Immunophenotyping | Cell Movement - drug effects | Macrophages - metabolism | Phenotype | Interleukin-6 - pharmacology | Models, Biological | Cell Line, Tumor | Aged | Cell Proliferation - drug effects | CD11b Antigen - metabolism | Neoplasm Staging | Receptors, Interleukin-6 - metabolism | Viral antibodies | Interleukins | Antibodies | Comparative analysis | Health aspects | Ovarian cancer | Cell proliferation | Therapy | Biotechnology | Ovarian carcinoma | Disease | Interleukin | Paracrine signalling | Metastasis | Macrophages | CD14 antigen | Cancer therapies | Interleukin 6 | Pretreatment | University graduates | Medical research | CD11b antigen | Cytokines | Gynecology | Gene expression | Epithelium | Patients | Obstetrics | Molecular chains | Medicine | Hormone replacement therapy | University faculty | Ascites | Binding sites | Cancer | Peritoneum
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 10/2017, Volume 22, Issue 5, pp. 921 - 926
Journal Article
International Journal of Advanced Robotic Systems, ISSN 1729-8814, 10/2019, Volume 16, Issue 5, p. 172988141987679
With increase in the number of elderly people in the Japanese society, traffic accidents caused by elderly driver is considered problematic. The primary factor... 
driving cognitive support system | ROBOTICS | Driving behavior modeling | hidden Markov model | BEHAVIOR | Support systems | Elderly people | Accuracy | Trustworthiness | Head-up displays | Time series | Accident prevention | Markov chains | Probabilistic models | Traffic accidents | Avoidance
Journal Article
PloS one, ISSN 1932-6203, 2016, Volume 11, Issue 3, p. e0151050
Objective The objective of this study was to evaluate the antitumor effects of lurbinectedin as a single agent or in combination with existing anticancer... 
RESISTANT | IRINOTECAN HYDROCHLORIDE CPT-11 | NUCLEOTIDE-EXCISION-REPAIR | SOLID TUMORS | CISPLATIN | MULTIDISCIPLINARY SCIENCES | THERAPEUTIC TARGET | TOPOTECAN | TRABECTEDIN | PHASE-I | CANCER | Doxorubicin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Ovarian Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Cisplatin - administration & dosage | Mechanistic Target of Rapamycin Complex 1 | Multiprotein Complexes - antagonists & inhibitors | TOR Serine-Threonine Kinases - antagonists & inhibitors | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Female | Ovary - drug effects | Paclitaxel - administration & dosage | Carbolines - therapeutic use | Ovarian Neoplasms - drug therapy | Doxorubicin - administration & dosage | Heterocyclic Compounds, 4 or More Rings - administration & dosage | Ovary - pathology | Carbolines - administration & dosage | Paclitaxel - therapeutic use | Drug Synergism | Animals | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Cell Line, Tumor | Adenocarcinoma, Clear Cell - pathology | Mice | Adenocarcinoma, Clear Cell - drug therapy | Complications and side effects | Anthracyclines | Chemotherapy | Dosage and administration | Research | Drug therapy | Ovarian cancer | Cancer | Biotechnology | Transcription | Clinical trials | Cancer therapies | Doxorubicin | Anticancer properties | Synergistic effects | Salvage | Antitumor agents | Platinum | Paclitaxel | Xenografts | Lesions | Drug dosages | Deoxyribonucleic acid--DNA | University graduates | Medical research | Immunoglobulins | Gynecology | Obstetrics | Cisplatin | Medicine | Studies | Irinotecan | Antitumor activity | Synergistic effect | Deoxyribonucleic acid | DNA
Journal Article
Journal Article
Electronics and Communications in Japan, ISSN 1942-9533, 02/2018, Volume 101, Issue 2, pp. 74 - 86
Journal Article
Journal Article
Journal Article